Myriad Genetics EVP reports 93,493-share stake
MYRIAD GENETICS INC (MYGN) reported an initial statement of beneficial ownership for Vishal Sikri, who serves as EVP, Commercial.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
MYRIAD GENETICS INC (MYGN) reported an initial statement of beneficial ownership for Vishal Sikri, who serves as EVP, Commercial. The filing lists 93,493 shares of Common Stock held with direct ownership after the reported event, and does not report any concurrent purchases, sales, or derivative positions.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Sikri Vishal
Role
EVP, Commercial
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock | -- | -- | -- |
Holdings:
Common Stock — 93,493 shares (Direct)
Key Figures
Common Stock beneficially owned: 93,493 shares
Ownership type: Direct
Reporting person role: EVP, Commercial
3 metrics
Common Stock beneficially owned
93,493 shares
Shares of Myriad Genetics common stock beneficially owned following the reported event
Ownership type
Direct
Ownership of the reported 93,493 Myriad Genetics common shares is classified as direct
Reporting person role
EVP, Commercial
Officer title of reporting person Vishal Sikri at Myriad Genetics Inc
Key Terms
beneficial ownership, Form 3, Common Stock, Power of Attorney
4 terms
beneficial ownership financial
"reported an initial statement of beneficial ownership for Vishal Sikri"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Form 3 regulatory
"The Form 3 records his initial beneficial ownership position"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Common Stock financial
"93,493 shares of Common Stock held with direct ownership"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Power of Attorney regulatory
"Exhibit 24 - Power of Attorney"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is the reporting insider in MYGN’s latest Form 3 filing?
The reporting insider is Vishal Sikri, who is identified as EVP, Commercial at Myriad Genetics Inc. The Form 3 records his initial beneficial ownership position in the company’s common stock.
Does this MYGN Form 3 report any insider buying or selling activity?
No. The Form 3 lists a holding entry only and shows no reported purchases or sales of Myriad Genetics common stock. It is an initial beneficial ownership report, not a transaction Form 4 or Form 5.
What type of security is reported in Vishal Sikri’s MYGN Form 3?
The filing reports ownership of Common Stock of Myriad Genetics Inc. No options, warrants, or other derivative securities are listed in the derivative holdings section of this Form 3.
Is any Rule 10b5-1 trading plan disclosed in this MYGN Form 3?
No. The data indicate no Rule 10b5-1 trading plan is reported in connection with this Form 3. The filing serves only to disclose Mr. Sikri’s existing beneficial ownership of common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
